| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CARDINAL HEALTH INC | CEO, PSS Segment | Common Shares | 49.8K | $5.37M | $107.91 | Aug 16, 2024 | Direct |
| CARDINAL HEALTH INC | CEO, PSS Segment | Employee Stock Option (right to buy) | 0 | $51.49 | Nov 27, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CAH | CARDINAL HEALTH INC | Aug 15, 2024 | 3 | -$1.31M | 4 | Aug 19, 2024 | CEO, PSS Segment |
| CAH | CARDINAL HEALTH INC | Aug 13, 2024 | 1 | $0 | 4 | Aug 14, 2024 | CEO, PSS Segment |
| CAH | CARDINAL HEALTH INC | Dec 1, 2023 | 1 | -$68.3K | 4 | Dec 5, 2023 | CEO, Pharmaceutical Segment |
| CAH | CARDINAL HEALTH INC | Nov 27, 2023 | 7 | -$1.85M | 4 | Nov 29, 2023 | CEO, Pharmaceutical Segment |
| CAH | CARDINAL HEALTH INC | Aug 28, 2023 | 3 | -$123K | 4 | Aug 29, 2023 | CEO, Pharmaceutical Segment |
| CAH | CARDINAL HEALTH INC | Aug 15, 2023 | 2 | -$1.02M | 4 | Aug 17, 2023 | CEO, Pharmaceutical Segment |
| CAH | CARDINAL HEALTH INC | Aug 7, 2023 | 1 | $0 | 4 | Aug 8, 2023 | CEO, Pharmaceutical Segment |
| CAH | CARDINAL HEALTH INC | Dec 1, 2022 | 1 | -$30.5K | 4 | Dec 5, 2022 | CEO, Pharmaceutical Segment |
| CAH | CARDINAL HEALTH INC | Sep 19, 2022 | 0 | $0 | 3 | Sep 29, 2022 | CEO, Pharmaceutical Segment |